Yuan Ji to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Yuan Ji has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
1.576
-
The i3+3 design for phase I clinical trials. J Biopharm Stat. 2020 03; 30(2):294-304.
Score: 0.569
-
A modified toxicity probability interval method for dose-finding trials. Clin Trials. 2010 Dec; 7(6):653-63.
Score: 0.310
-
Risk-group-specific dose finding based on an average toxicity score. Biometrics. 2010 Jun; 66(2):541-8.
Score: 0.285
-
Dose-finding in phase I clinical trials based on toxicity probability intervals. Clin Trials. 2007; 4(3):235-44.
Score: 0.239
-
Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials. J Clin Oncol. 2013 May 10; 31(14):1785-91.
Score: 0.092
-
Monitoring late-onset toxicities in phase I trials using predicted risks. Biostatistics. 2008 Jul; 9(3):442-57.
Score: 0.064
-
Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation. Stat Med. 2008 Oct 30; 27(24):4895-913.
Score: 0.017